Oncoheroes Biosciences receives a second investment from The Andrew McDonough B+ Foundation

by Oncoheroes Biosciences

In October 2019, The Andrew McDonough B+ Foundation invested for the first time in Oncoheroes Biosciences, a biotech company advancing new therapies for childhood cancer. The B+ Foundation was the fir...

Read more

Oncoheroes Biosciences And The Scott Carter Foundation Are Onboard To End Childhood Cancer

by Oncoheroes Biosciences

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S. cancer diagnoses. Because of improved tumor detection and treatment advances in recent decades, 84% of children wit...

Read more

SJD Barcelona Children's Hospital, among the best centers in the world for the treatment of neuroblastoma

by Fundació Sant Joan de Déu

The accumulated experience and the personalized care offered, places Sant Joan de Déu among the best international centres for the treatment of this childhood cancer

Read more

Oncoheroes Biosciences And Swifty Foundation United Toward New Cures

by Oncoheroes Biosciences

Childhood cancer is considered a rare disease that accounts for about 1% of all U.S cancers.

Read more

MEET A HERO: Grant, 2 year old at diagnosis

by Oncoheroes Biosciences

"Upside down," said Grant looking at himself in the mirror and pointing at his Spiderman T-shirt while standing up on a hospital bed. Grant Gossling was 2 years old when he was diagnosed with high-ris...

Read more

Oncoheroes Joins the Coalition Against Childhood Cancer (CAC2)

by Oncoheroes Biosciences

Oncoheroes today announced its organizational membership into the Coalition Against Childhood Cancer, known as CAC2, a collaborative network of organizations and individuals supporting and servicing t...

Read more

CNIO researchers granted EU funds to study new treatment for childhood cancer

by CNIO - Centro Nacional de Investigaciones Oncológicas

Óscar Fernández-Capetillo, Head of the Genomic Instability ​Group at the Spanish National Cancer Research Centre (CNIO), has just received the European Research Council (ERC) Proof of Concept Gran...

Read more

A study proposes a new approach for the identification of a syndrome of predisposition to childhood cancer

by Hospital Universitari de Bellvitge

Patients with this syndrome have more mutations in the microsatellite regions of the genome. The detection of these mutations improves the diagnosis and therapeutic management of patients.

Read more

Bioengineering contributes to new advances against childhood cancer

by IBEC - Institut de Bioenginyeria de Catalunya

IBEC contributes to elucidate how the rigidity of the tumor extracellular matrix affects the aggressiveness of neuroblastoma, a cancerous tumor that affects mainly children. This opens the door to gen...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Highlight

Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

La saliva del gusano de la cera contiene...

by CSIC - Centro Superior de Investigaciones Científicas

Un equipo de investigadores del CSIC ha descubierto que la saliva del ...

Photos Stream